ETHAN - ET for Male BC | Vanderbilt-Ingram Cancer Center

ETHAN - ET for Male BC

This research study is looking to see how well male breast cancer responds to preoperative treatment with endocrine therapy and which endocrine therapy regimen is the most effective treatment for male breast cancer.

The drugs used in this study are:

* Tamoxifen
* Anastrozole
* Degarelix
* Abemaciclib

Disease Sites:

Breast

Staging:

Phase II

Age Group:

Adults

Therapies:

Hormonal Therapy

Drugs:

Abemaciclib, Anastrozole, Degarelix, Tamoxifen

Principal Investigator(s):

Sharpe, Jessica

Scope:

National

Participating Institutions:

Vanderbilt University

Open Date:

12-19-2025

Trial Type:

Treatment

Protocol ID:

VICCBRE25028

National Clinical Trial ID:

NCT05501704

Eligibility

Ages Eligible for Study:

18 Years and older

Genders Eligible for Study:

MALE

Accepts Healthy Volunteers?:

false

Clinical Trials Search at Vanderbilt-Ingram Cancer Center

ETHAN - ET for Male BC

Eligibility